Medpage Today and U.S. National Library of Medicine — Early results of the REDUCE-IT (Reduction of Cardiovascular Events With EPA - Intervention Trial) study show that when combined with a cholesterol-lowering statin, the fish-oil drug Vascepa significantly lowers the risk of major cardiovascular events, according to the manufacturer. |
|
No comments:
Post a Comment